After testing 70 different drugs over 10 years, Australian cancer researchers have discovered a new drug that holds great promise for treating children with an aggressive form of leukaemia.
Environmental chemical exposure is a valid concern, but the evidence does not support hyperbolic claims that we are swimming in a soup of cancer-causing chemicals, writes Darren Saunders.
Her vision is to use nanotechnology to deliver drugs and gene-silencing therapies directly to cancer cells. He is a social scientist with an interest in the social and ethical issues of technological change.
Research assessing the impact of genomic testing on women with a high-risk of developing breast cancer has received backing in the latest round of funding from the Cancer Council NSW.
A new gene sequencing technology being used to map the human genome is set to transform the diagnosis of cancer and other diseases, potentially saving lives.
Cancer screening is beneficial when it prevents people from dying. But using cancer survival rates to promote screening, as is often done, is misleading, write Katy Bell, Alexandra Barratt and Andrew Hayen.
Premier Mike Baird has opened Stage One of a $80 million cancer treatment and research centre that will bring together elite researchers and clinicians in one building.
UNSW research into childhood cancers, HIV prevention, and sexually transmissible diseases in remote Aboriginal communities has received major backing in the latest round of federal government health funding.
The molecular mysteries that allow cancers, viruses and autoimmune diseases to dodge the body’s defence mechanisms will come under the microscope at a new ARC Centre of Excellence.
